We are live on
!
Find out more
MAP
Moody Aldrich Partners Portfolio holdings
AUM
$557M
1-Year Est. Return
122.79%
This Fund
S&P 500
This Quarter
Est. Return
+17.61%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$556M
AUM Growth
+$28.1M
(+5.3%)
Cap. Flow
-$40.2M
Cap. Flow
% of AUM
-7.23%
Top 10 Holdings %
Top 10 Hldgs %
17.22%
Holding
230
New
38
Increased
44
Reduced
92
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
The Bancorp
TBBK
|
+$6.97M |
| 2 |
LNW
Light & Wonder
LNW
|
+$6.69M |
| 3 |
e.l.f. Beauty
ELF
|
+$4.06M |
| 4 |
CONMED
CNMD
|
+$4.04M |
| 5 |
ESCO Technologies
ESE
|
+$4.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kinsale Capital Group
KNSL
|
+$11.6M |
| 2 |
HealthEquity
HQY
|
+$6.56M |
| 3 |
ALE
Allete
ALE
|
+$4.77M |
| 4 |
Hilton Grand Vacations
HGV
|
+$4.72M |
| 5 |
IMGN
Immunogen Inc
IMGN
|
+$4.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.18% |
| 2 | Healthcare | 16.22% |
| 3 | Technology | 15.16% |
| 4 | Industrials | 13.7% |
| 5 | Consumer Discretionary | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRNA
26
DELISTED
Verona Pharma
VRNA
| $6.38M | 1.15% |
321,161
-33,676
| -9% | -$497K |
|
27
Helen of Troy
HELE
$693M
| $6.37M | 1.15% |
52,729
+2,576
| +5% | +$278K |
|
28
Element Solutions
ESI
$9.23B
| $6.32M | 1.14% |
273,135
+24,852
| +10% | +$502K |
|
29
Nextpower Inc
NXT
$15.7B
| $6.29M | 1.13% |
134,357
+72,441
| +117% | +$2.83M |
|
|
CBAY
30
DELISTED
Cymabay Therapeutics
CBAY
| $6.17M | 1.11% |
261,415
-64,562
| -20% | -$1.15M |
|
31
Albany International
AIN
$1.78B
| $6.16M | 1.11% |
62,718
-6,663
| -10% | -$581K |
|
|
PR
32
Permian Resources
PR
$16.9B
| $6.06M | 1.09% |
445,591
-232,920
| -34% | -$3.19M |
|
33
Chord Energy
CHRD
$7.39B
| $5.95M | 1.07% |
35,782
-14,436
| -29% | -$2.36M |
|
34
Asbury Automotive
ABG
$3.85B
| $5.91M | 1.06% |
26,267
-2,756
| -9% | -$583K |
|
35
STAG Industrial
STAG
$7.19B
| $5.86M | 1.05% |
149,185
-15,782
| -10% | -$560K |
|
36
Meritage Homes
MTH
$4.86B
| $5.84M | 1.05% |
67,072
+27,076
| +68% | +$1.87M |
|
37
Varonis Systems
VRNS
$5B
| $5.77M | 1.04% |
127,429
-3,734
| -3% | -$140K |
|
38
Forestar Group
FOR
$1.51B
| $5.76M | 1.04% |
174,113
-42,800
| -20% | -$1.24M |
|
|
MZTI
39
The Marzetti Company
MZTI
$3.11B
| $5.55M | 1% |
33,363
+4,270
| +15% | +$717K |
|
40
Axsome Therapeutics
AXSM
$10.9B
| $5.32M | 0.96% |
66,866
-6,767
| -9% | -$452K |
|
|
CPRX
41
DELISTED
Catalyst Pharmaceutical
CPRX
| $5.18M | 0.93% |
307,912
+34,400
| +13% | +$470K |
|
42
Atkore
ATKR
$3.16B
| $5.14M | 0.92% |
32,113
+5,957
| +23% | +$822K |
|
43
CACI
CACI
$14.2B
| $5.12M | 0.92% |
15,814
-9,022
| -36% | -$2.93M |
|
|
44
e.l.f. Beauty
ELF
$5.8B
| $5.07M | 0.91% |
+35,155
| New | +$4.06M |
|
45
BridgeBio Pharma
BBIO
$16.5B
| $5.05M | 0.91% |
124,984
-12,528
| -9% | -$376K |
|
46
Qualys
QLYS
$6.35B
| $4.93M | 0.89% |
25,127
+8,257
| +49% | +$1.44M |
|
|
BCPC
47
Balchem Corp
BCPC
$5.72B
| $4.93M | 0.89% |
33,121
-3,492
| -10% | -$446K |
|
48
Portland General Electric
POR
$5.77B
| $4.87M | 0.88% |
112,337
-3,868
| -3% | -$161K |
|
|
DO
49
DELISTED
Diamond Offshore Drilling, Inc.
DO
| $4.86M | 0.87% |
373,781
-144,126
| -28% | -$1.86M |
|
50
Option Care Health
OPCH
$3.56B
| $4.7M | 0.85% |
139,439
-49,201
| -26% | -$1.51M |
|
Similar funds
CAM
QL
TCM
CFP
TC
DIM
NCA
CA
Moody Aldrich Partners's Q4 2023 Portfolio in Review
As of Q4 2023, Moody Aldrich Partners held 230 positions worth $556M, up 5.3% from $528M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Moody Aldrich Partners withdrew a net $40.2M in Q4 2023, closing 35 positions and reducing 92 holdings. Its most notable exit was HealthEquity, an estimated $6.56M position sold in full.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Moody Aldrich Partners opened a new position in The Bancorp worth $7.18M.
- Moody Aldrich Partners's largest Q4 2023 buy was The Bancorp: 186,299 shares worth $7.18M.
- Moody Aldrich Partners added most to Leonardo DRS in Q4 2023, an estimated $3.28M increase.
- Moody Aldrich Partners's biggest Q4 2023 reduction was Kinsale Capital Group, cutting an estimated $11.6M.
- Moody Aldrich Partners fully exited HealthEquity in Q4 2023, selling an estimated $6.56M.
- Moody Aldrich Partners's ten largest holdings make up 17% of its $556M portfolio in Q4 2023.
- Moody Aldrich Partners opened 38 new positions and closed 35 in Q4 2023.
- Moody Aldrich Partners's portfolio value rose 5.3% quarter-over-quarter to $556M.
Based on Moody Aldrich Partners's 13F filing for Q4 2023, filed 26 Jan 2024.